- Presentations
- 4
- Markets
- 1
Belsomra is a brand of Suvorexant marketed by Merck Sharp & Dohme, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Suvorexant
- Brand owner
- Merck Sharp & Dohme
- Registered in
- United States
- Strengths and forms
- 10 mg tablet, 15 mg tablet, 20 mg tablet, 5 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Belsomra 10 mg tabletOral | Merck Sharp & Dohme | US FDA | Available on request |
| Belsomra 15 mg tabletOral | Merck Sharp & Dohme | US FDA | Available on request |
| Belsomra 20 mg tabletOral | Merck Sharp & Dohme | US FDA | Available on request |
| Belsomra 5 mg tabletOral | Merck Sharp & Dohme | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Belsomra
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.